The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694.

In ferrets, the selective 5-hydroxytryptamine (5-HT) 5-HT3 receptor antagonist BRL 43694 given as a single injection (0.05-0.5 mg kg-1 i.v.) before cisplatin, or by divided dose (2 x 0.005-2 x 0.5 mg kg-1 i.v.) before and after cisplatin dramatically reduced or abolished the severe cisplatin-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Bermudez, J., Boyle, E. A., Miner, W. D., Sanger, G. J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1988
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246836/
https://www.ncbi.nlm.nih.gov/pubmed/2851311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246836/
https://www.ncbi.nlm.nih.gov/pubmed/2851311

Ejemplares similares